X-66172339-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001367233.3(HEPH):c.168-16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 1,170,780 control chromosomes in the GnomAD database, including 29,981 homozygotes. There are 84,358 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.37 ( 8052 hom., 11133 hem., cov: 22)
Exomes 𝑓: 0.22 ( 21929 hom. 73225 hem. )
Consequence
HEPH
NM_001367233.3 intron
NM_001367233.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0640
Genes affected
HEPH (HGNC:4866): (hephaestin) This gene encodes a member of the multicopper oxidase protein family. The encoded protein is involved in the transport of dietary iron from epithelial cells of the intestinal lumen into the circulatory system, and may be involved in copper transport and homeostasis. In mouse, defects in this gene can lead to severe microcytic anemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant X-66172339-T-C is Benign according to our data. Variant chrX-66172339-T-C is described in ClinVar as [Benign]. Clinvar id is 3256823.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEPH | NM_001367233.3 | c.168-16T>C | intron_variant | ENST00000343002.7 | NP_001354162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEPH | ENST00000343002.7 | c.168-16T>C | intron_variant | 1 | NM_001367233.3 | ENSP00000343939.2 |
Frequencies
GnomAD3 genomes AF: 0.365 AC: 40134AN: 109959Hom.: 8042 Cov.: 22 AF XY: 0.344 AC XY: 11089AN XY: 32249
GnomAD3 genomes
AF:
AC:
40134
AN:
109959
Hom.:
Cov.:
22
AF XY:
AC XY:
11089
AN XY:
32249
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.245 AC: 37247AN: 152157Hom.: 5268 AF XY: 0.228 AC XY: 10259AN XY: 44933
GnomAD3 exomes
AF:
AC:
37247
AN:
152157
Hom.:
AF XY:
AC XY:
10259
AN XY:
44933
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.220 AC: 233825AN: 1060774Hom.: 21929 Cov.: 29 AF XY: 0.216 AC XY: 73225AN XY: 338884
GnomAD4 exome
AF:
AC:
233825
AN:
1060774
Hom.:
Cov.:
29
AF XY:
AC XY:
73225
AN XY:
338884
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.365 AC: 40190AN: 110006Hom.: 8052 Cov.: 22 AF XY: 0.345 AC XY: 11133AN XY: 32306
GnomAD4 genome
AF:
AC:
40190
AN:
110006
Hom.:
Cov.:
22
AF XY:
AC XY:
11133
AN XY:
32306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 31, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 25. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at